查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1420986

兒科保健產品和服務市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Pediatric Health Care Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

兒科保健產品和服務市場 - 報告範圍

TMR 關於全球兒科保健產品和服務市場的報告研究了過去以及當前的成長趨勢和機會，以獲得2023 年至2031 年預測期內市場指標的寶貴見解。該報告提供了全球兒科保健產品和服務市場的收入2017-2031年兒科保健產品及服務市場，以2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球兒科保健產品和服務市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解兒科保健產品和服務市場。

市場概況
2023年市場價值 956 億美元
2031 年市場價值 1735 億美元
CAGR 6.9%

該報告深入研究了全球兒科保健產品和服務市場的競爭格局。全球兒科保健產品和服務市場的主要參與者已經確定，並且每個參與者都根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球兒科保健產品和服務市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2023-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 關鍵疾病/紊亂/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依疾病/失調分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依疾病/失調分類，2023-2031
    • 過敏和呼吸系統
    • 癌症
    • 心血管
    • 中樞神經系統
    • 胃腸道
    • 荷爾蒙失衡
    • 感染
    • 其他
  • 市場吸引力：依疾病/失調分類

第 7 章：全球市場分析與預測：按藥物類別

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依藥品類別，2023-2031
    • 抗生素
    • 止痛藥
    • 平喘藥
    • 抗憂鬱藥
    • 止瀉藥
    • 抗真菌劑
    • 抗組織胺藥
    • 抗高血壓藥
    • 抗代謝藥
    • 抗腫瘤抗生素
    • 抗精神病藥
    • 其他
    • 市場吸引力：按藥品類別

第 8 章：全球市場分析與預測：按服務分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依服務分類，2023-2031
    • 兒童精神科服務
    • 腸胃服務
    • 兒科癌症服務
    • 小兒糖尿病服務
    • 小兒心臟服務
    • 其他
  • 市場吸引力：依服務分類

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2023-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第 10 章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第 12 章：亞太市場分析與預測

第 13 章：拉丁美洲市場分析與預測

第 14 章：中東和非洲市場分析與預測

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • AstraZeneca plc
    • Boehringer Ingelheim GmbH
    • Eisai Co., Ltd.
    • Gilead Sciences, Inc.
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Mylan NV
    • Novartis AG
    • Pediapharm, Inc.
    • Pfizer, Inc.
    • Sanofi SA
Product Code: TMRGL12236

Pediatric Health Care Products and Services Market - Scope of Report

TMR's report on the global pediatric health care products and services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global pediatric health care products and services market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pediatric health care products and services market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pediatric health care products and services market.

Market Snapshot
Market Value in 2023US$ 95.6 Bn
Market Value in 2031US$ 173.5 Bn
CAGR6.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global pediatric health care products and services market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global pediatric health care products and services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pediatric health care products and services market.

The report delves into the competitive landscape of the global pediatric health care products and services market. Key players operating in the global pediatric health care products and services market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pediatric health care products and services market profiled in this report.

Key Questions Answered in Global pediatric health care products and services Market Report:

  • What is the sales/revenue generated by pediatric health care products and services across all regions during the forecast period?
  • What are the opportunities in the global pediatric health care products and services market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Pediatric Health Care Products and Services Market - Research Objectives and Research Approach

The comprehensive report on the global pediatric health care products and services market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global pediatric health care products and services market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pediatric health care products and services market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pediatric Health Care Products and Services Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Pediatric Health Care Products and Services Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Disease/Disorder/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Pediatric Health Care Products and Services Market Analysis and Forecast, by Disease/Disorder

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Disease/Disorder, 2023-2031
    • 6.3.1. Allergy and Respiratory
    • 6.3.2. Cancer
    • 6.3.3. Cardiovascular
    • 6.3.4. Central Nervous System
    • 6.3.5. Gastrointestinal
    • 6.3.6. Hormonal Imbalance
    • 6.3.7. Infections
    • 6.3.8. Others
  • 6.4. Market Attractiveness, by Disease/Disorder

7. Global Pediatric Health Care Products and Services Market Analysis and Forecast, by Drug Class

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Drug Class, 2023-2031
    • 7.3.1. Antibiotics
    • 7.3.2. Analgesics
    • 7.3.3. Anti-asthmatics
    • 7.3.4. Antidepressants
    • 7.3.5. Antidiarrheal
    • 7.3.6. Antifungal
    • 7.3.7. Anti-histamines
    • 7.3.8. Antihypertensives
    • 7.3.9. Anti-metabolites
    • 7.3.10. Anti-neoplastic Antibiotics
    • 7.3.11. Antipsychotics
    • 7.3.12. Others
    • 7.3.13. Market Attractiveness, by Drug Class

8. Global Pediatric Health Care Products and Services Market Analysis and Forecast, by Service

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Service, 2023-2031
    • 8.3.1. Child Psychiatry Services
    • 8.3.2. Gastrointestinal Services
    • 8.3.3. Pediatric Cancer Services
    • 8.3.4. Pediatric Diabetes Services
    • 8.3.5. Pediatric Heart Services
    • 8.3.6. Others
  • 8.4. Market Attractiveness, by Service

9. Global Pediatric Health Care Products and Services Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2023-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Region

10. North America Pediatric Health Care Products and Services Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Disease/Disorder, 2023-2031
    • 10.2.1. Allergy and Respiratory
    • 10.2.2. Cancer
    • 10.2.3. Cardiovascular
    • 10.2.4. Central Nervous System
    • 10.2.5. Gastrointestinal
    • 10.2.6. Hormonal Imbalance
    • 10.2.7. Infections
    • 10.2.8. Others
  • 10.3. Market Attractiveness, by Disease/Disorder
  • 10.4. Market Value Forecast, by Drug Class, 2023-2031
    • 10.4.1. Antibiotics
    • 10.4.2. Analgesics
    • 10.4.3. Anti-asthmatics
    • 10.4.4. Antidepressants
    • 10.4.5. Antidiarrheal
    • 10.4.6. Antifungal
    • 10.4.7. Anti-histamines
    • 10.4.8. Antihypertensives
    • 10.4.9. Anti-metabolites
    • 10.4.10. Anti-neoplastic Antibiotics
    • 10.4.11. Antipsychotics
    • 10.4.12. Others
  • 10.5. Market Attractiveness, by Drug Class
  • 10.6. Market Value Forecast, by Service, 2023-2031
    • 10.6.1. Child Psychiatry Services
    • 10.6.2. Gastrointestinal Services
    • 10.6.3. Pediatric Cancer Services
    • 10.6.4. Pediatric Diabetes Services
    • 10.6.5. Pediatric Heart Services
    • 10.6.6. Others
  • 10.7. Market Attractiveness, by Service
  • 10.8. Market Value Forecast, by Country, 2023-2031
    • 10.8.1. U.S.
    • 10.8.2. Canada
  • 10.9. Market Attractiveness Analysis
    • 10.9.1. By Disease/Disorder
    • 10.9.2. By Drug Class
    • 10.9.3. By Service
    • 10.9.4. By Country

11. Europe Pediatric Health Care Products and Services Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Disease/Disorder, 2023-2031
    • 11.2.1. Allergy and Respiratory
    • 11.2.2. Cancer
    • 11.2.3. Cardiovascular
    • 11.2.4. Central Nervous System
    • 11.2.5. Gastrointestinal
    • 11.2.6. Hormonal Imbalance
    • 11.2.7. Infections
    • 11.2.8. Others
  • 11.3. Market Attractiveness, by Disease/Disorder
  • 11.4. Market Value Forecast, by Drug Class, 2023-2031
    • 11.4.1. Antibiotics
    • 11.4.2. Analgesics
    • 11.4.3. Anti-asthmatics
    • 11.4.4. Antidepressants
    • 11.4.5. Antidiarrheal
    • 11.4.6. Antifungal
    • 11.4.7. Anti-histamines
    • 11.4.8. Antihypertensives
    • 11.4.9. Anti-metabolites
    • 11.4.10. Anti-neoplastic Antibiotics
    • 11.4.11. Antipsychotics
    • 11.4.12. Others
  • 11.5. Market Attractiveness, by Drug Class
  • 11.6. Market Value Forecast, by Service, 2023-2031
    • 11.6.1. Child Psychiatry Services
    • 11.6.2. Gastrointestinal Services
    • 11.6.3. Pediatric Cancer Services
    • 11.6.4. Pediatric Diabetes Services
    • 11.6.5. Pediatric Heart Services
    • 11.6.6. Others
  • 11.7. Market Attractiveness, by Service
  • 11.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.8.1. Germany
    • 11.8.2. U.K.
    • 11.8.3. France
    • 11.8.4. Italy
    • 11.8.5. Spain
    • 11.8.6. Rest of Europe
  • 11.9. Market Attractiveness Analysis
    • 11.9.1. By Disease/Disorder
    • 11.9.2. By Drug Class
    • 11.9.3. By Service
    • 11.9.4. By Country/Sub-region

12. Asia Pacific Pediatric Health Care Products and Services Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Disease/Disorder, 2023-2031
    • 12.2.1. Allergy and Respiratory
    • 12.2.2. Cancer
    • 12.2.3. Cardiovascular
    • 12.2.4. Central Nervous System
    • 12.2.5. Gastrointestinal
    • 12.2.6. Hormonal Imbalance
    • 12.2.7. Infections
    • 12.2.8. Others
  • 12.3. Market Attractiveness, by Disease/Disorder
  • 12.4. Market Value Forecast, by Drug Class, 2023-2031
    • 12.4.1. Antibiotics
    • 12.4.2. Analgesics
    • 12.4.3. Anti-asthmatics
    • 12.4.4. Antidepressants
    • 12.4.5. Antidiarrheal
    • 12.4.6. Antifungal
    • 12.4.7. Anti-histamines
    • 12.4.8. Antihypertensives
    • 12.4.9. Anti-metabolites
    • 12.4.10. Anti-neoplastic Antibiotics
    • 12.4.11. Antipsychotics
    • 12.4.12. Others
  • 12.5. Market Attractiveness, by Drug Class
  • 12.6. Market Value Forecast, by Service, 2023-2031
    • 12.6.1. Child Psychiatry Services
    • 12.6.2. Gastrointestinal Services
    • 12.6.3. Pediatric Cancer Services
    • 12.6.4. Pediatric Diabetes Services
    • 12.6.5. Pediatric Heart Services
    • 12.6.6. Others
  • 12.7. Market Attractiveness, by Service
  • 12.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.8.1. China
    • 12.8.2. Japan
    • 12.8.3. India
    • 12.8.4. Australia & New Zealand
    • 12.8.5. Rest of Asia Pacific
  • 12.9. Market Attractiveness Analysis
    • 12.9.1. By Disease/Disorder
    • 12.9.2. By Drug Class
    • 12.9.3. By Service
    • 12.9.4. By Country/Sub-region

13. Latin America Pediatric Health Care Products and Services Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Disease/Disorder, 2023-2031
    • 13.2.1. Allergy and Respiratory
    • 13.2.2. Cancer
    • 13.2.3. Cardiovascular
    • 13.2.4. Central Nervous System
    • 13.2.5. Gastrointestinal
    • 13.2.6. Hormonal Imbalance
    • 13.2.7. Infections
    • 13.2.8. Others
  • 13.3. Market Attractiveness, by Disease/Disorder
  • 13.4. Market Value Forecast, by Drug Class, 2023-2031
    • 13.4.1. Antibiotics
    • 13.4.2. Analgesics
    • 13.4.3. Anti-asthmatics
    • 13.4.4. Antidepressants
    • 13.4.5. Antidiarrheal
    • 13.4.6. Antifungal
    • 13.4.7. Anti-histamines
    • 13.4.8. Antihypertensives
    • 13.4.9. Anti-metabolites
    • 13.4.10. Anti-neoplastic Antibiotics
    • 13.4.11. Antipsychotics
    • 13.4.12. Others
  • 13.5. Market Attractiveness, by Drug Class
  • 13.6. Market Value Forecast, by Service, 2023-2031
    • 13.6.1. Child Psychiatry Services
    • 13.6.2. Gastrointestinal Services
    • 13.6.3. Pediatric Cancer Services
    • 13.6.4. Pediatric Diabetes Services
    • 13.6.5. Pediatric Heart Services
    • 13.6.6. Others
  • 13.7. Market Attractiveness, by Service
  • 13.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.8.1. Brazil
    • 13.8.2. Mexico
    • 13.8.3. Rest of Latin America
  • 13.9. Market Attractiveness Analysis
    • 13.9.1. By Disease/Disorder
    • 13.9.2. By Drug Class
    • 13.9.3. By Service
    • 13.9.4. By Country/Sub-region

14. Middle East & Africa Pediatric Health Care Products and Services Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Disease/Disorder, 2023-2031
    • 14.2.1. Allergy and Respiratory
    • 14.2.2. Cancer
    • 14.2.3. Cardiovascular
    • 14.2.4. Central Nervous System
    • 14.2.5. Gastrointestinal
    • 14.2.6. Hormonal Imbalance
    • 14.2.7. Infections
    • 14.2.8. Others
  • 14.3. Market Attractiveness, by Disease/Disorder
  • 14.4. Market Value Forecast, by Drug Class, 2023-2031
    • 14.4.1. Antibiotics
    • 14.4.2. Analgesics
    • 14.4.3. Anti-asthmatics
    • 14.4.4. Antidepressants
    • 14.4.5. Antidiarrheal
    • 14.4.6. Antifungal
    • 14.4.7. Anti-histamines
    • 14.4.8. Antihypertensives
    • 14.4.9. Anti-metabolites
    • 14.4.10. Anti-neoplastic Antibiotics
    • 14.4.11. Antipsychotics
    • 14.4.12. Others
  • 14.5. Market Attractiveness, by Drug Class
  • 14.6. Market Value Forecast, by Service, 2023-2031
    • 14.6.1. Child Psychiatry Services
    • 14.6.2. Gastrointestinal Services
    • 14.6.3. Pediatric Cancer Services
    • 14.6.4. Pediatric Diabetes Services
    • 14.6.5. Pediatric Heart Services
    • 14.6.6. Others
  • 14.7. Market Attractiveness, by Service
  • 14.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.8.1. GCC Countries
    • 14.8.2. South Africa
    • 14.8.3. Rest of Middle East & Africa
  • 14.9. Market Attractiveness Analysis
    • 14.9.1. By Disease/Disorder
    • 14.9.2. By Drug Class
    • 14.9.3. By Service
    • 14.9.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. AstraZeneca plc
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Disease/Disorder Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Boehringer Ingelheim GmbH
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Disease/Disorder Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Eisai Co., Ltd.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Disease/Disorder Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Gilead Sciences, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Disease/Disorder Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. GlaxoSmithKline plc
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Disease/Disorder Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Merck & Co., Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Disease/Disorder Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Mylan N.V.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Disease/Disorder Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Novartis AG
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Disease/Disorder Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Pediapharm, Inc.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Disease/Disorder Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Pfizer, Inc.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Disease/Disorder Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Sanofi S.A.
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Disease/Disorder Portfolio
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023-2031
  • Table 02: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023-2031
  • Table 03: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023-2031
  • Table 04: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Region, 2023-2031
  • Table 05: North America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Country, 2023-2031
  • Table 06: North America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023-2031
  • Table 07: North America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023-2031
  • Table 08: North America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023-2031
  • Table 09: Europe Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Europe Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023-2031
  • Table 11: Europe Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023-2031
  • Table 12: Europe Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023-2031
  • Table 13: Asia Pacific Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 14: Asia Pacific Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023-2031
  • Table 15: Asia Pacific Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023-2031
  • Table 16: Asia Pacific Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023-2031
  • Table 17: Latin America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 18: Latin America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023-2031
  • Table 19: Latin America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023-2031
  • Table 20: Latin America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023-2031
  • Table 21: Middle East & Africa Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Middle East & Africa Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023-2031
  • Table 23: Middle East & Africa Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023-2031
  • Table 24: Middle East & Africa Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023-2031

List of Figures

  • Figure 01: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn), by Disease/Disorder, 2022
  • Figure 03: Global Pediatric Health Care Products and Services Market Value Share, by Disease/Disorder, 2022
  • Figure 04: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn), by Drug Class, 2022
  • Figure 05: Global Pediatric Health Care Products and Services Market Value Share, by Drug Class, 2022
  • Figure 06: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn), by Service, 2022
  • Figure 07: Global Pediatric Health Care Products and Services Market Value Share, by Service, 2022
  • Figure 08 Global Pediatric Health Care Products and Services Market Value Share, by Region, 2022
  • Figure 09: Global Pediatric Health Care Products and Services Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031
  • Figure 11: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2023-2031
  • Figure 12: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 13: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 14: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031
  • Figure 15: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023-2031
  • Figure 16: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 17: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Pediatric Health Care Products and Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 19: North America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Pediatric Health Care Products and Services Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 21: North America Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031
  • Figure 22: North America Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 23: North America Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031
  • Figure 24: North America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2023-2031
  • Figure 25: North America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 26: North America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023-2031
  • Figure 27: Europe Pediatric Health Care Products and Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 28: Europe Pediatric Health Care Products and Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Pediatric Health Care Products and Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 30: Europe Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031
  • Figure 31: Europe Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 32: Europe Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031
  • Figure 33: Europe Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2023-2031
  • Figure 34: Europe Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 35: Europe Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023-2031
  • Figure 36: Asia Pacific Pediatric Health Care Products and Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 37: Asia Pacific Pediatric Health Care Products and Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Pediatric Health Care Products and Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Asia Pacific Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031
  • Figure 40: Asia Pacific Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 41: Asia Pacific Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031
  • Figure 42: Asia Pacific Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2022-2031
  • Figure 43: Asia Pacific Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 44: Asia Pacific Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023-2031
  • Figure 45: Latin America Pediatric Health Care Products and Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 46: Latin America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Pediatric Health Care Products and Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Latin America Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031
  • Figure 49: Latin America Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 50: Latin America Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031
  • Figure 51: Latin America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2023-2031
  • Figure 52: Latin America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 53: Latin America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023-2031
  • Figure 54: Middle East & Africa Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 55: Middle East & Africa Pediatric Health Care Products and Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Pediatric Health Care Products and Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 57: Middle East & Africa Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031
  • Figure 58: Middle East & Africa Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031
  • Figure 59: Middle East & Africa Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031
  • Figure 60: Middle East & Africa Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2023-2031
  • Figure 61: Middle East & Africa Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 62: Middle East & Africa Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023-2031